Drug firm Torrent Pharmaceuticals today reported 2.97 per cent increase in net profit for the for the second quarter ended September 30 to Rs 76.19 crore.
Net profit for the same quarter last fiscal was at Rs 73.99 crore, the company said in a statement.
Total income for the period under review stood at Rs 581.51 crore, as against Rs 479.62 crore in the same quarter last fiscal.
For the half year ended September 30, consolidated net profit rose to Rs 150.41 crore from Rs 89.11 crore. The total income during the period stood at Rs 1122.51 crore as against Rs 960.67 for the same period last year, it added.
Torrent Pharma also said that its Board in its meeting held on October 23, 2010 has accepted resignation of Kiran Karnik as Director of the Company and has appointed Shailesh V Haribhakti as an additional director.
Shares of Torrent Pharma were trading at Rs 557 on the BSE in the afternoon trade down 1.82 per cent from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
